Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20 536 individuals-Reference-Cited by-同舟云学术

Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20 536 individuals

Published:2005-05 Issue:9473 Volume:365 Page:1779-1785
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Publisher

Elsevier BV

Subject

General Medicine

Reference19 articles.

1. MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience;Eur Heart J,1999

2. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial;Lancet,2002

3. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial;Lancet,2003

4. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high risk conditions;Lancet,2004

5. Trust financial returns,2001

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis;Cochrane Database of Systematic Reviews;2023-11-29

2. Antioxidant Effects of Statins by Modulating Nrf2 and Nrf2/HO-1 Signaling in Different Diseases;Journal of Clinical Medicine;2022-02-27

3. Long-term monitoring in primary care for chronic kidney disease and chronic heart failure: a multi-method research programme;Programme Grants for Applied Research;2021-08

4. Two steps forward, one step back: 50 years of societal value from LDL-C-lowering therapies;The American Journal of Managed Care;2021-04-01

5. The Lancet Commission on diabetes: using data to transform diabetes care and patient lives;The Lancet;2020-12